158 related articles for article (PubMed ID: 32872145)
1. Discharging Preterm Infants Home on Caffeine, a Single Center Experience.
Ma C; Broadbent D; Levin G; Panda S; Sambalingam D; Garcia N; Ruiz E; Singh AP
Children (Basel); 2020 Aug; 7(9):. PubMed ID: 32872145
[No Abstract] [Full Text] [Related]
2. Association between Apnea of Prematurity and Respiratory Distress Syndrome in Late Preterm Infants: An Observational Study.
Olivier F; Nadeau S; Caouette G; Piedboeuf B
Front Pediatr; 2016; 4():105. PubMed ID: 27725928
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of pharmaceutically compounded oral caffeine on the impact of medication adherence and risk of readmission among preterm neonates: A single-center quasi-experimental study.
Ambreen G; Kumar M; Ali A; Shah SAA; Saleem SM; Tahir A; Salat MS; Aslam MS; Hussain K
PLoS One; 2022; 17(11):e0275655. PubMed ID: 36350877
[TBL] [Abstract][Full Text] [Related]
4. A cost-effectiveness analysis for high versus standard (low) dose caffeine for the treatment of apnea in neonatal intensive care unit.
Al-Hersh E; Abushanab D; AbouNahia F; Rainkie D; Al Hail M; Abdulrouf PV; El-Kassem W; Al-Badriyeh D
J Pharm Policy Pract; 2024; 17(1):2345218. PubMed ID: 38798766
[TBL] [Abstract][Full Text] [Related]
5. The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study.
Lista G; Fabbri L; Polackova R; Kiechl-Kohlendorfer U; Papagaroufalis K; Saenz P; Ferrari F; Lasagna G; Carnielli VP;
Neonatology; 2016; 109(3):221-7. PubMed ID: 26820884
[TBL] [Abstract][Full Text] [Related]
6. Sex-based differences in apnoea of prematurity: A retrospective cohort study.
Bairam A; Laflamme N; Drolet C; Piedboeuf B; Shah PS; Kinkead R;
Exp Physiol; 2018 Oct; 103(10):1403-1411. PubMed ID: 29974527
[TBL] [Abstract][Full Text] [Related]
7. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
[TBL] [Abstract][Full Text] [Related]
8. [Recent research on gene polymorphisms related to caffeine therapy in preterm infants with apnea of prematurity].
Xie JB; Lin XZ
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jul; 24(7):832-837. PubMed ID: 35894202
[TBL] [Abstract][Full Text] [Related]
9. Developing and testing a clinical care bundle incorporating caffeine citrate to manage apnoea of prematurity in a resource-constrained setting: a mixed methods clinical feasibility study protocol.
Irimu G; Okwaro F; Coleman J; Waiyego M; Murila F; Chomba D; Parsimei M; Shitote C; Ochieng R; Shah J; Ogero M; Ginsburg AS; Ansermino JM; Macharia W
Implement Sci Commun; 2023 Jul; 4(1):80. PubMed ID: 37461120
[TBL] [Abstract][Full Text] [Related]
10. Early Discharge of Preterm Infants- An Indian Perspective.
Soni A; Kadam S; Pandit A; Patole S
J Clin Diagn Res; 2016 Dec; 10(12):SC21-SC23. PubMed ID: 28208967
[TBL] [Abstract][Full Text] [Related]
11. [Safety and efficacy of caffeine use started at different time in preterm infants: a multicenter study in Jiangsu Province, China].
Yang Y; Cheng R; Wu Q; Qiao LX; Yang ZM; Gu HB; Jiang SY; Liu SL; Jiang SH
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Feb; 22(2):130-135. PubMed ID: 32051079
[TBL] [Abstract][Full Text] [Related]
12. Economics of Home Monitoring for Apnea in Late Preterm Infants.
Montenegro BL; Amberson M; Veit L; Freiberger C; Dukhovny D; Rhein LM
Respir Care; 2017 Jan; 62(1):42-48. PubMed ID: 28003553
[TBL] [Abstract][Full Text] [Related]
13. Significance of Intermittent Hypoxic Episodes in Premature Infants Prior to Discharge.
Alalaiyan S; Shakeeb D; Al Hazzani F; Binmanee A
Cureus; 2023 Mar; 15(3):e36113. PubMed ID: 37065300
[TBL] [Abstract][Full Text] [Related]
14. Comparative Efficacy and Safety of Caffeine and Aminophylline for Apnea of Prematurity in Preterm (≤34 weeks) Neonates: A Randomized Controlled Trial.
Shivakumar M; Jayashree P; Najih M; Lewis LES; Bhat Y R; Kamath A; Shashikala -
Indian Pediatr; 2017 Apr; 54(4):279-283. PubMed ID: 28474588
[TBL] [Abstract][Full Text] [Related]
15. Clinical associations of immature breathing in preterm infants: part 1-central apnea.
Fairchild K; Mohr M; Paget-Brown A; Tabacaru C; Lake D; Delos J; Moorman JR; Kattwinkel J
Pediatr Res; 2016 Jul; 80(1):21-7. PubMed ID: 26959485
[TBL] [Abstract][Full Text] [Related]
16. Caffeine in preterm infants: where are we in 2020?
Moschino L; Zivanovic S; Hartley C; Trevisanuto D; Baraldi E; Roehr CC
ERJ Open Res; 2020 Jan; 6(1):. PubMed ID: 32154294
[TBL] [Abstract][Full Text] [Related]
17. Intermittent hypoxia in preterm infants: Measurement using the desaturation index.
Wellington G; Campbell A; Elder D
Pediatr Pulmonol; 2019 Jun; 54(6):865-872. PubMed ID: 30924319
[TBL] [Abstract][Full Text] [Related]
18. The effect of venous caffeine on the prevention of apnea of prematurity in the very preterm infants in the neonatal intensive care unit of Shahid Motahhari Hospital, Urmia, during a year.
Fakoor Z; Makooie AA; Joudi Z; Asl RG
J Adv Pharm Technol Res; 2019; 10(1):16-19. PubMed ID: 30815383
[TBL] [Abstract][Full Text] [Related]
19. Prediction of postdischarge complications by predischarge event recordings in infants with apnea of prematurity.
Subhani M; Katz S; DeCristofaro JD
J Perinatol; 2000 Mar; 20(2):92-5. PubMed ID: 10785883
[TBL] [Abstract][Full Text] [Related]
20. Duration of home monitoring for infants discharged with apnea of prematurity.
Tauman R; Sivan Y
Biol Neonate; 2000 Oct; 78(3):168-73. PubMed ID: 11044764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
